Impact BioMedical Inc. (IBO) stock
Close on Oct 19, 2026Market cap $26.14MP/E –Yield –
Impact BioMedical statistics
31 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- –
Share statisticsIndustry
- Shares Change (QoQ)
- 0.37%
- 0.50%
- Float
- 7M
- 49M
- Shares Held by Insiders
- 14.9%
- 11.7%
MarginsIndustry
- Pretax Margin
- -2560.5%
- -11.6%
- EBITDA Margin
- -9657.9%
- -27.7%
Returns on capitalIndustry
- Return on Assets (ROA)
- 9.32%
- -40.6%
- Return on Capital Employed (ROCE)
- -34.2%
- -37.9%
Financial positionIndustry
- Current Ratio
- 0.04
- 3.30
- Quick Ratio
- 0.01
- 2.39
GrowthIndustry
- Revenue Growth (3Y CAGR)
- -13.8%
- 2.25%
EfficiencyIndustry
- Asset Turnover
- 0.00
- 0.40
- Revenue Per Employee
- $19.00K
- $429.29K
- Profits Per Employee
- $807.00K
- -$689.41K
- Employee Count
- 2
- 74
Income statement (TTM)Industry
- Pretax Income
- -$973.00K
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $21.00K
- $17.76M
- Net Cash Per Share
- $0.00
- $0.80
- Equity (Book Value)
- $10.12M
- $53.89M
- Book Value Per Share
- $1.18
- $1.50
- Tangible Book Value
- -$6.02M
- $27.13M
- Working Capital
- -$2.27M
- $79.99M
Cash flow (TTM)Industry
Scores and fair valueIndustry
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | IBO | S&P 500 | Difference | IBO per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +418.6% | +0.6% | +418.0 pts | ||
| 3 months | +571.1% | +3.4% | +567.7 pts | ||
| Year to date | +505.9% | +13.3% | +492.7 pts | ||
| 1 year | +413.3% | +16.6% | +396.7 pts |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M IBO shares were sold short on Oct 30, 2026, down 6.4% from the previous report. At recent volumes it would take 1.1 days to buy them back. Over the last 20 sessions, 41.1% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 24,619 | -6.4% | 21,408 | 1.1 |
| Oct 15, 2026 | 26,292 | -12.9% | 12,841 | 2.0 |
| Sep 30, 2026 | 30,169 | -94.3% | 15,208 | 2.0 |
| Sep 15, 2026 | 526,986 | -2.1% | 530,594 | 1.0 |
| Aug 31, 2026 | 538,182 | -1.5% | 27,947 | 19.3 |
| Aug 14, 2026 | 546,651 | -1.5% | 41,408 | 13.2 |
| Jul 31, 2026 | 554,915 | -0.4% | 20,507 | 27.1 |
| Jul 15, 2026 | 557,404 | +0.2% | 55,705 | 10.0 |
| Jun 30, 2026 | 556,491 | -10.4% | 75,355 | 7.4 |
| Jun 15, 2026 | 621,006 | -17.2% | 96,609 | 6.4 |
| May 29, 2026 | 750,055 | -4.3% | 34,559 | 21.7 |
| May 15, 2026 | 783,895 | -22.5% | 57,414 | 13.7 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?